Stay updated on Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Sign up to get notified when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    Change Detected
    Summary
    The page now displays a new Revision: v3.6.6 label, indicating a minor build/version update.
    Difference
    0.1%
    Check dated 2026-08-29T23:46:25.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The page's revision tag was updated from v3.6.4 to v3.6.5, reflecting a backend/page update.
    Difference
    0.1%
    Check dated 2026-08-08T20:27:16.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page’s revision number has been updated from v3.6.3 to v3.6.4. This change represents a minor site release with no impact on the study details or visible content.
    Difference
    0.1%
    Check dated 2026-07-25T12:46:26.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.3, replacing the previous Revision: v3.6.2. This reflects a minor update to the page’s version history.
    Difference
    0.1%
    Check dated 2026-07-03T23:58:58.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.6.2, replacing the previous v3.6.0, indicating a site version update. This metadata change does not alter the study details or how users interact with the page.
    Difference
    0.1%
    Check dated 2026-06-26T23:16:13.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    The page now indicates the study is not recruiting participants, clarifying its current status. It also adds new guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates the Intervention/Treatment heading formatting along with a revision tag (v3.6.0).
    Difference
    0.5%
    Check dated 2026-06-12T13:45:12.000Z thumbnail image

Stay in the know with updates to Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combining Pembrolizumab and PEG-Intron for Cholangiocarcinoma Clinical Trial page.